News About: Goverment
KFDA to set fast review standards for new BT products.
To expedite rapid commercialization of the bio drugs, the health regulatory agency is going to establish a review standard and a supporting system, which may guide for the BT R&D to see its direction far in advance or...
MOHW and AZ to agree more R&D cooperation.
The MOHW has made an MOU with AstraZeneca (AZ), a British based foreign multinational drug corporation, for the R&D and clinical study cooperation at a global level.
Minister Ryu Si-min signed the MOU on April 5 ...
R&D infra for New drugs to be driven by KFDA.
Under the KFDA's leadership, it is expected that "2007 New Drug Infra Buildup Project" seems to run for the activation of the new drug development as a pan national strategic projects.
The lst 5 year plan starts fr...
60 drug makers to penalize on charge of direct sales to hospitals.
It was found that more than 900 drugs were directly sold by drug makers to hospitals, which is illegal and therefore subjected to penalize possibly ranged from the business suspension and fine. The KFDA said on April ...
KFDA to establish D/B for drug registration.
The KFDA already undertook an establishment of DB for the drug registration, which may provide more accurate and credible drug informations in the future.
The project was purported for the information services of d...
689 hospitals to charge on unfair bills last year.
The total 689 medical institutions billed false charges last year in the amount to 8.9 billion won, showing 13 million won per an institution on average.
The MOHW disclosed the above status on April 4 after investi...
National Assembly to curb government's KFDA split move.
The government movement for the current KFDA to split into the Food Safety Agency and the Drug Safety Division affiliated to the MOHW seems to be curbed at the National Assembly.
A strong opposition has been surfa...
New drugs developed by local companies not successful on markets.
The 11th new drug developed by a local drug company may be introduced soon but the marketability of those new drugs has not made any progress at all. 7 in 10 new drugs in Korea showed less than 2 billion won of an...
Bio-equivalency test for 60 ingredients including Cefaclor mandatory.
Of the drug ingredients that were not proven of its bio-equivalency, the KFDA designated 60 ingredients including Cefaclor to be verified mandatorily.
The KFDA announced the detailed bio equivalency reviews before ...
International Conference of Drug Regulatory opened.
The health regulatory officers from all worlds have shared a common perception that an international cooperation be absolutely necessary for the new drug development, the good medicine supply and the monitoring of new...
